Corrigendum to “Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure” [J Mol Cell Cardiol 47 (2009) 288–295, (S0022282809002211), (10.1016/j.yjmcc.2009.05.009)];Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 2, 2009, Pages 288-295

  Shintani, Yasunori ^a   Fukushima, Satsuki ^b   Varela Carver, Anabel ^b   Lee, Joon ^b   Coppen, Steven R ^a   Takahashi, Kunihiko ^a   Brouilette, Scott W ^a   Yashiro, Kenta ^a   Terracciano, Cesare M N ^b   Yacoub, Magdi H ^b   Suzuki, Ken ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Bone marrow mononuclear cells; Cell therapy; Heart failure; Paracrine effect; Signal transduction; Skeletal myoblasts

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATE BUFFERED SALINE; PROTEIN KINASE B; PROTEIN KINASE D; SCATTER FACTOR; SMAD3 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SIZE; CELL TYPE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DONOR; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING;

RATTUS;

EID: 67649111104     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2024.01.001     Document Type: Erratum

References (29)

1. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112 20 (2005 Nov 15) 3174-3183
2. Fukushima S., Varela-Carver A., Coppen S., Yamahara K., Felkin L., Lee J., et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115 17 (2007 May) 2254-2261
3. Fukushima S., Coppen S., Lee J., Yamahara K., Felkin L., Terracciano C., et al. Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS ONE 3 8 (2008) e3071
4. Kinnaird T., Stabile E., Burnett M.S., and Epstein S.E. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ. Res. 95 4 (2004 Aug 20) 354-363
5. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 11 (2006 Jun) 1414-1421
6. Gnecchi M., Zhang Z., Ni A., and Dzau V. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103 11 (2008 Nov) 1204-1219
7. Burchfield J., Iwasaki M., Koyanagi M., Urbich C., Rosenthal N., Zeiher A., et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ. Res. 103 2 (2008 Jul) 203-211
8. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W., Zeiher A., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39 5 (2005 Nov) 733-742
9. Suzuki K., Murtuza B., Smolenski R., Sammut I., Suzuki N., Kaneda Y., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104 12 Suppl 1 (2001 Sep) I207-I212
10. Popping S., Mruck S., Fischer Y., Kulsch D., Ionescu I., Kammermeier H., et al. Economy of contraction of cardiomyocytes as influenced by different positive inotropic interventions. Am. J. Physiol. 271 1 Pt 2 (1996 Jul) H357-H364
11. Terracciano C.M., Souza A.I., Philipson K.D., and MacLeod K.T. Na+-Ca2+ exchange and sarcoplasmic reticular Ca2+ regulation in ventricular myocytes from transgenic mice overexpressing the Na+-Ca2+ exchanger. J. Physiol. 512 Pt 3 (1998 Nov 1) 651-667
12. Liu Y., Yang X., Nass O., Sabbah H., Peterson E., and Carretero O. Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. Am. J. Physiol. 272 2 Pt 2 (1997 Feb) H722-H727
13. Murtuza B., Suzuki K., Bou-Gharios G., Beauchamp J., Smolenski R., Partridge T., et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl. Acad. Sci. U. S. A. 101 12 (2004 Mar) 4216-4221
14. Heineke J., and Molkentin J. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 7 8 (2006 Aug) 589-600
15. Chen J., Somanath P., Razorenova O., Chen W., Hay N., Bornstein P., et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11 11 (2005 Nov) 1188-1196
16. Osugi T., Oshima Y., Fujio Y., Funamoto M., Yamashita A., Negoro S., et al. Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J. Biol. Chem. 277 8 (2002 Feb 22) 6676-6681
17. Shiojima I. Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20 24 (2006 Dec 15) 3347-3365
18. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross Jr. J., et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97 2 (1999 Apr 16) 189-198
19. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95 2 (2004 Jul 23) 187-195
20. Murry C., Soonpaa M., Reinecke H., Nakajima H., Nakajima H., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 6983 (2004 Apr) 664-668
21. Pfeffer M., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 4 (1990 Apr) 1161-1172
22. P. Fedak, S. Verma, R. Weisel, M. Skrtic, R. Li, Cardiac remodeling and failure: from molecules to man (Part III). Cardiovasc Pathol 14(3):109-119.
23. Jacoby J.J., Kalinowski A., Liu M.G., Zhang S.S., Gao Q., Chai G.X., et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc. Natl. Acad. Sci. U. S. A. 100 22 (2003 Oct 28) 12929-12934
24. Kontaridis M.I., Yang W., Bence K.K., Cullen D., Wang B., Bodyak N., et al. Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways. Circulation 117 11 (2008 Mar 18) 1423-1435
25. Yamaguchi O., Watanabe T., Nishida K., Kashiwase K., Higuchi Y., Takeda T., et al. Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. J. Clin. Invest. 114 7 (2004 Oct) 937-943
26. Hill J., and Olson E. Cardiac plasticity. N. Engl. J. Med. 358 13 (2008 Mar) 1370-1380
27. Purcell N.H., Wilkins B.J., York A., Saba-El-Leil M.K., Meloche S., Robbins J., et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 104 35 (2007 Aug 28) 14074-14079
28. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12 4 (2006 Apr) 459-465
29. Suzuki K., Sawa Y., Kaneda Y., Ichikawa H., Shirakura R., and Matsuda H. In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat. J. Clin. Invest. 99 7 (1997 Apr 1) 1645-1650